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Chemically or photochemically generated *0 2 (*Ag 0 2 ) transforms the anion of dithranol (1) into 
chrysazine (2), probably via an erafo-peroxide. Under basic conditions, 3 0 2 converts 1 to the 
bisanthrone 3 and to dithranol brown. The anion of dithranol is a photosensitizer. l 0 2 was trapped by 
2,3-dimethyl-2-butene and by methyl oleate which was converted to the C-9- and C-10-
hydroperoxides. From this point of view interference of the antipsoriatic dithranol with the 
metabolism of arachidonic acid appears reasonable. 
Dithranol, Singulett-Sauerstoff und ungesättigte Fettsäuren 
Chemisch bzw. photochemisch erzeugter *0 2 (*Ag 0 2 ) überführt das Dithranol (1)-Anion in 
Chrysazin (2), vermutlich über ein Endoperoxid. - Unter basischen Bedingungen entstehen aus 1 mit 
3 0 2 das Bianthron 3 und sog. Dithranolbraun. Dithranol (1) -Anion ist selbst ein Photosensibilisator, 
1 0 2 wurde mit 2,3-Dimethyl-2-buten bzw. mit Ölsäuremethylester abgefangen, der zu den entspr. 
C-9- bzw. C-10-Hydroperoxiden umgesetzt wird. Von hier aus sind Eingriffe des Antipsoriatikums 
Dithranol (1) in den Arachidonsäurestoffwechsel denkbar. 
The lability of the antipsoriatic compound dithranol (1) is well known1*. Especially under basic 
conditions chrysazine (2) and l,8,l%8'-tetrahydroxy-10,10'-bisanthrone (3) and the so-called 
dithranol brown arise very quickly. These components are ineffective against psoriasis. According to 
Mustakallio2) 3 is formed via a. radical intermediate whose structure was elucidated by Davies3). 
Therefore, we regard 3 to be a 30 2-oxidation product. On the other hand, Schultz and Frey4) have 
synthesized Diels-Alder-adducts using dithranol as a diene under basic conditions. In addition, 
Retzow5) obtained the same compounds even in a slightly acidic medium. From this point of view a 
reaction of 1-anion with *0 2 is conceivable. 
In dipolar, aprotic solvents 1 is deprotonated at least partially5* to the 1,8,9-
trihydroxyanthracene-anion which is converted to 2 by 1 0 2 . 102 is generated by 
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NaOCl/H 20 2, by thermal decomposition of l,4-dimethylnaphthalene-l,4-endoperoxide 
or by photosensibilisation (tetraphenylporphyrine - TPP). No reaction occurs between 1 
and 102 in CH2C12* where 1 exists as the pertinent anthrone (Xmax = 355 nm). Under basic 
conditions 3 is converted rapidly to the corresponding bisanthranole6), which is also 
transformed to 2 by 1 0 2 . On the other hand, 1 is converted only to 3 and dithranol brown 
using NaOCl, H 2 0 2 and Fentorts reagent. Therefore, two oxidation pathways can be 
differentiated: with x02 there arises 2, a typical x02 product; whilst 3 and dithranol brown 
are formed by 3 0 2 under basic conditions. Table 1 shows the percentage of 2 and 3 after 4 h. 
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Table 1: Percentage of 2 and 3 after 4 h 
a b c 
2 67% 32% _ 
3 19% 14% 42% 
a: TTP/irradiation; b: no TPP/irrädiation; c: no TPP/no irradition. - differences to 100%: 1 and/or 
dithranol brown 
* We are grateful to Prof. Dr. G . Wurm, Berlin, for this private communication (H.-J. Duchstein and 
G. Wurm, Arch. Pharm. (Weinheim 317, 809 (1984)). 
Fig. 1: Time course for the conversion of 1 to 2 
• TPP/100 W/0 2 / A no TPP/100 W / 0 2 / O no TPP/daylight/air/ A TPP/light protection^ 
According to Table 1 and Figure 1,2 is formed from the 1-anion even without addition of 
a photosensitizer. Therefore, 1-anion was irradiated together with 2,3-dimethyl-2-buten 
leading to 2,3-dimethyl-l-buten-3-hydroperoxide, a typical 102-product {Schenck-
reaction7)). Contrary to their behaviour in biological experiments8*, 2 and 3-enol do show 
photosensitizing properties under our more vigorous conditions. 
Dithranol - a Sensitizer 
0°.Na-lamp 
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If the 102-quencher ß-carotene9) is added to experiments with 2,3-dimethyl-2-butene, no 
hydroperoxide is formed; the photooxidation of 1-anion to 2 was inhibited significantly 
(Fig. 2) by ß-carotene. 
The necessity of increasing concentrations of ß-carotene in order to prevent the 
oxidation of 1 to 2 is explained by the degradation of ß-carotene by 1 O 2 1 0 ) (Fig. 3): 50 % of 
the ß-carotene are already destroyed after 20 h. 
As indicated in the introduction, 1 acts as a diene. Therefore, the formation of 2 was 
assumed to proceed via a [4+2]-cycloaddition of l02 to 1-anion leading to the pertinent 
9,10-endoperoxide. In order to support this hypothesis, 1,8,9-trimethoxyanthracene (4) 
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Fig. 2: Photooxygenation of dithranol: inhibition by ß-carotene 
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Fig. 3: Time course of the decomposition of ß-carotene (5 • 10"3 M) 
The corresponding 9,10-endoperoxide was found as the pertinent intermediate by 
nmr-spectroscopy at 0°C: the singulet of C-10-H in 4 (6= 8.02 ppm) was shifted to 
5.74ppm (endoperoxide); when the sample was allowed to warm up to 35° in the nmr 
spectrometer, the intensity of the singulet at 5.74 ppm decreased, whilst the MeOH signal 
increased. 
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The bisanthrone 3 was cleaved by 1 0 2 to 2, moreover dithranol brown was formed. 2 was 
resistant to 1 0 2 . 
The reactivity of 1 as a photosensitizer and the conversion of 2,3-dimethyl-2-butene into the 
pertinent hydroperoxide point towards a conceivable interference of dithranol (1) and unsatured fatty 
acids under antipsoriatic therapy. In psoriatic epidermis, the concentrations of arachidonic acid and 
12-hydroxy-5,8,10,14-eicosatetraenic acid are increased 25- and 81-fold, resp., as compared to 
unaffected skin, whilst the Prostaglandines E 2 and F 2 c t are increased by only 40 % and 86 % n \ This 
indicates that the cyclooxygenase system is slightly increased while the lipoxygenase activity is greatly 
so 1 2 ). Other groups demonstrated a significant reduction in Prostaglandine E and F syntheses in 
psoriatic skin to about 50 % of the normal rate 1 3 ' 1 4 ). A n inhibitor of the cyclooxygenase system was 
found in psoriatic plaques15). A participation of 1 0 2 in the Prostaglandine synthesis was assumed, 
because the activity of the Prostaglandine synthetase system was diminished by 102-trapping or 
quenching. Moreover, low concentrations of these trappers and quenchers are supposed to protect the 
Prostaglandine synthetase and the pertinent peroxidase from autocatalysed degradation or 
inactivation by peroxides16). Although there are many reports of 1 0 2 involvement in biological 
systems, there has not been a direct detection of 1 0 2 in a biological reaction up to now. None of the 
techniques which have been used appear to be completely specific for 1 0 2 and a new type of 
electron-transfer oxygenation gives rise to products which are identical of those obtained from 1 0 2 
reactions17). 
According to Mustakallio18) an activation of the cyclooxygenase pathway leads to an increased level 
of inflammatory mediators, e. g. endoperoxides or Prostaglandines, which are responsible for the 
unpleasant side effects - erythema and irritation of the uneffected skin - under dithranol (1) therapy. 
Latest results, however, indicate that 1 inhibits the lipoxygenase dependent production of 12-HETE, 
whilst cyclooxygenase dependent processes are not significantly affected19): these are only a few of 
many (partially) contradictory statements. 
x02 converts unsaturated fatty acids to hydroperoxides, bearing the -OOH-group at 
those C-atoms which were part of the former C=C-bond20,21). Radicalic autoxidation (302) 
attacks the allylic positions22). Unna23) has already performed experiments so as to 
elucidate an interaction of chrysarobin (1, with an additional CH3-group at C-3) and oleic 
acid. We photooxygenated methyloleate as a model compound, using 1-anion as a 
sensitizer. The positions of the OOH-groups were determined by reduction to the 
corresponding saturated hydroxy acids which on the other hand were reoxidized to the 
ketones. These molecules were separated from stearinic acid and identified by GC-MS, 
making use of a-cleavage and McLa/jfe/*y-rearrangement ions: we obtained the 
102-products selectively, bearing the HOO-groups at C-9 and C-10, resp. No regioselec-
tivity was observed. Therefore, we did not extend our experiments to manifold 
unsaturated fatty acids. 
The financial support of the Deutsche Forschungsgemeinschaft for this project is gratefully 
acknowledged. 
Experimental Part 
Apparatus: MP: (uncorr.): apparatus according to Dr. Tottoli; IR: Beckman Acculab III; 1H-NMR: 
Varian E M 390 (90MHz), CDC1 3 , 35°, TMS as int. stand. UV: Shimadzu 210, MeOH Uvasol 
„Merck", 1cm sample thickness; MS: Varian M A T C H 5, excitation energy 70eV; densitometer: 
Shimadzu TLC-Scanner CS 910 with Servogor two-channel recorder, model 2 S. 
Materials: l,8-dihydroxy-9-anthrone (dithranol, l)24* was purified by column chromatography 
(Si0 2 /CH 2 C1 2 ). - l,8-dihydroxy-9,10-anthraquinone (chrysazine, 2): commercially available (Syn-
ochem); l,8,l',8'-tetrahydroxybisanthrone (S)24*; l^^-trimethoxy-anthracene^)25*; 1,8-dimethoxy-
9,10-anthraquinone (S)26*. Solvents for photochemical reactions and densitometric determinations 
were of analytical grade (,,Merck"). 
General remarks 
a) Photochemical reactions: photosensitized oxidations of 1, 3 and 4 were performed in test tubes, 
closed by serum caps, which were placed in a glass cylinder (12 cm diameter) filled with MeOH. The 
methanol was cooled by a Haake cryostat. 0 2 was introduced into the reaction mixture via a frit D 4 , 
the test tubes were irradiated by a cooled halogen lamp (Osram Halostar, 100 W) fixed at a distance of 
5 cm from the reaction vessel. Irradiation conditions: 4h at -10°C, unless otherwise stated. 
b) Quantitative determination of the reaction products27^. 2 x 2 ul of the sample and 2 x 2; 4; 6 and 8 ul 
of the standard solutions (2mg of the authentic subst. in 10.00 ml CH 2C1 2) were spotted by a 
Hamilton-syringe on a tic plate (Silica F 2 5 4 ) . Development with toluene/glacial acetic acid (97:3, -vol) 
for 2 and 3, with toluene for 5. Densitometric determination by measuring the reflected part of the 
incident monochromatic light. X max of the absorption spectra, taken in reflection technique: 2: 
430 nm; 3: 365 nm; 5: 380 nm. 
Oxidation ofl with chemically generated 102 
a) with H ^ / N a O C l 2 8 * : 22.6mg (0.1 mmol) 1 in 10ml M e O H were cooled to 5°C under N 2 in the 
dark; after addition of 0.15 ml H 2 0 2 (30 %), 1 ml NaOCl-solution (15 %) was added under stirring 
over 10 min. The originally yellow solution became deep red. After 1 h the oxidation products were 
identified by tic; comparision with authentic materials was made. 
b) With l,4-dihydro-l,4-dimethylnaphthalene-l,4-endoperoxide29): l g 1,4-dimethylnaphthalene 
and 5mg methylene blue in 25 ml CH 2 C1 2 were irradiated under 0 2 at -10°C for 3h. After 
evaporation of CH 2 C1 2 , the endoperoxide crystallized. Half of the reaction product and 50 mg 1 in 
20 ml "solvent" (CH 2Cl 2/DMF/pyridine 20:2:1 - vol) were refluxed under N 2 for 4 h in the dark. The 
oxidation products were identified by tic. - l,4-dihydro-l,4-dimethylnaphthalene-endoperoxide: 
^ - N M R (CDC1 3): 6 (ppm) = 1.85 (s; 6H, -CH 3 ) ; 6.65 (s; 2H, C-2-H, C-3-H); 7.15-7.35 (m; aromatic 
H's). 
Oxidation of 1 with 102 from photosensitization 
22.6mg (0.1 mmol) 1 and 2 mg TPP were irradiated in 10 ml "solvent" under 0 2 . At hourly intervals 
2 x 2 ul samples were removed for densitometric analysis. 
Proof of photosensitizing properties in 1, 2, 3 and 4 
0.1 mmol of the compounds mentioned above and 100 mg 2,3-dimethyl-2-butene in 5 ml "solvent" 
were irradiated under 0 2 . After evaporation of the solvents i . vac. the residues were dissolved in 5 ml 
CDCI3. 2,3-dimethyl-l-butene-3-hydroperoxide7, ^ was characterized by nmr-spectroscopy. 1 H -
N M R (CDCI3): 6 (ppm)= 1.0 (s; 6H, -CH 3 ) , 1.50 (s; 3H, H 3 C-C=C), 4.57-4.74 (m; 2H, 
=CH 2 ) . 
Quenching of 1-photooxygenation by ß-carotene 
22.6 mg (0.1 mmol) 1 and varying quantities of ß-carotene (Fig. 3) in 20 ml "solvent" were irradiated 
under 0 2 ; 2 was determined densitometrically. 
Determination of the decrease of ß-carotene during irradiation 
21mg (0.05 mmol) ß-carotene in 20 ml "solvent" were irradiated at -10 °C under 0 2. 20 ul samples 
taken at time zero and after 3; 6; 20 and 44 h were diluted to 5.00 ml by MeOH (Uvasol, Merck) and 
their extinctions determined at 448 nm (Xmax of ß-carotene) in 1 cm cuvets, using 20 ul "solvent" filled 
up to 5.00ml with MeOH as a blank. 
Photosensitized oxidation of 4 to 5 
270 mg 4 and 10 mg TPP in 20 ml CH 2 C1 2 were irradiated under 0 2 .5 was separated from 4 and TPP by 
column chromatography (Si0 2 /CH 2C1 2), the solution was evaporated to dryness i . vac: 5, mp. 223° 
(glacial acetic acid). Analytical data correspond to those of an authentic sample26). 
l,8,9-trimethoxyanthracene-9,10-dihydro-9,10-endoperoxide: an intermediate between 4 and 5 
a) Proof by formation of I 2:20 mg 4 and 5 mg TPP in 10 ml MeOH were irradiated at -10 °C under 0 2 . 
After 30 min bubbling of 0 2 and irradiation were stopped and after 1 further min 1 ml of KI/starch 
solution (Pharm. Eur.) was added: blue colour. Under identical conditions neither the solvent nor 5, 
TPP or the mixture of both reacted positively. 
b) Proof by nmr-spectroscopy: *H-NMR of 4: 6 (ppm) = 3.80 (s; 3H, O C H 3 at C-9), 3.90 (s; 6H, 
-OCH 3 ) , 6.59-6.72 (m; 2H, arom. H at C-4 and C-5), 7.12-7.49 (m; 4H, arom. H), 8.02 (s; 1H, arom. 
H at C-10). - 250 mg 4 and 10 mg TPP in 5 ml CDC1 3 were irradiated at -15 °C under 0 2 . After 30 min 
0.7 ml of the mixture were taken by a cooled syringe and used for nmr-spectroscopy: C-10-H was 
shifted to ö = 5.74ppm. This sample was slowly heated to 75 °C in the nmr-spectrometer: the spectra 
were taken at 15 (35°C); 30 (35°C); 60 (55°C) and 90 (75°C) min. The signal at 6= 5.74ppm 
decreased, whilst the singlet of MeOH at 6 = 3.35 ppm increased at the same rate. 
Oxidation of methyloleate, photosensitized by 1-anion 
Photooxidation: 2.96 g (0.01 mol) methyloleate and 10 mg 1 in 10 ml "solvent" were irradiated under 
0 2 at -10 °C for 6 h. Afterwards an additional 10 mg 1 were added and the irradiation was continued 
for further 6 h. Then the "solvent" was evaporated i . vac., the components were separated by column 
chromatography (Si0 2). With petrolether (b.p. 40-60°C) unchanged starting material was eluted; 
with ether/petrolether (1:5 - vol) 2 was eluted, followed by the mixture of hydroperoxides. Yield 
0.74 g (23 %) of hydroperoxides. 
9- and 10-oxo-methyloleates: the hydroperoxides mentioned above were dissolved in 50 ml E t O H and 
hydrogenated with 50 mg P t 0 2 under normal pressure and room temp, until the H2-consumption 
ceased. After filtration and evaporation i.vac. the residue was dissolved in 10ml acetone. With 
stirring 0.4 g C r 0 3 in 5 ml 5-N H 2 S 0 4 were added drop by drop to this solution; after completion 
stirring was continued for 15 min at room temp. After addition of 30 ml H 2 0 , the mixture was 
extracted with ether, the organic layer was washed with N a H C 0 3 solution, dried over N a 2 S 0 4 and 
evaporated to dryness i . vac. The mixture of the oxo-acids was separated from stearinic acid by gc: 
Column: fused silica O V 101 (8 m); Carrying gas H 2 , flow 2ml/min, split 10ml/min; column temp. 
80-170°C (5°C/min), 170° isotherm. Retention times: methylstearinate: 18.2min, 9-oxo- and 
10- oxo-methylstearinates: 26.4 min. The mixture of the oxo-esters was identified by ms3 1 ): M 2 = 
H 3 C-(CH 2 ) 7 -CO-(CH 2 ) 8 -CO-OCH 3 , M 2 = H 3 C-(CH 2 ) 8 -CO-(CH 2 ) 7 -CO-OCH 3 (fragments in italic 
figures). MS (70 eV): m/e = 312 (7%9MX+9 and M 2 + # ) , 214 (35%, M ^ M ^ H ^ ) , 200 (35%, 
M 2 + # - C 8 H # 1 6 ) , 170 (30%, M 2 + # - C 8 H 1 4 0 2 # , 156 (42%, M ^ - C ^ H ^ O * and M ^ - C ^ O ^ ) , 142 
(16 %, M 2 + # - C n H 2 1 0 # ) , 112 (9 %, M 2 + # - C 1 1 H 2 0 O 3 # ) , 98 (20 %, M ^ - C ^ H ^ O ^ ) , 74 (100 %, M ^ 
and M 2 + * - C 1 6 H 3 0 O * ) . 
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